Search results
UroGen Pharma Ltd.'s (NASDAQ:URGN) Prospects Need A Boost To Lift Shares
Simply Wall St. via Yahoo Finance· 1 year agoWith a price-to-sales (or "P/S") ratio of 3.5x UroGen Pharma Ltd. (NASDAQ:URGN) may be sending very...
Athira Pharma, Inc. (NASDAQ:ATHA) has caught the attention of institutional investors who hold a...
Simply Wall St. via Yahoo Finance· 2 years agoIf you want to know who really controls Athira Pharma, Inc. (NASDAQ:ATHA), then you'll have to look...
The Market Lifts Ocuphire Pharma, Inc. (NASDAQ:OCUP) Shares 42% But It Can Do More
Simply Wall St. via Yahoo Finance· 1 year agoOcuphire Pharma, Inc. (NASDAQ:OCUP) shareholders have had their patience rewarded with a 42% share...
Two Down With Sanofi Bowing Out From Horizon Buyout Talks, Amgen Agrees To Buy For $116.5/Share
Benzinga via Yahoo Finance· 2 years agoAmgen Inc (NASDAQ: AMGN) has agreed to buy Horizon Therapeutics plc (NASDAQ: HZNP), implying an...
3 Healthcare Stocks That Have Outperformed Nvidia Since 2022
Motley Fool via Yahoo Finance· 4 months agoTech giant Nvidia has been one of the hottest stocks over the past couple of years, with its shares...
The 3 Most Undervalued Pharma Stocks to Buy Now: July 2023
InvestorPlace via Yahoo Finance· 11 months agoPharma stocks experienced an abysmal first half due to various factors. Rotation from defensive to...
Not All of Big Tech Posted Magnificent Results for the 4th Quarter
GuruFocus.com via Yahoo Finance· 4 months agoDid Meta and Amazon just save earnings season? Big tech earnings kicked off earnings season last...
Missed Out on Eli Lilly? 2 Healthcare Stocks With Big Catalysts on the Horizon.
Motley Fool via Yahoo Finance· 2 months agoEli Lilly shares have soared more than 100% over the past year, bringing the company to a market...
Don’t Miss the Boom: 3 Pharma Stocks Set to Explode Higher
InvestorPlace via Yahoo Finance· 9 months agoThe pharmaceuticals market has taken a bit of a breather in recent weeks after an exhilarating rally...
Is Iovance Biotherapeutics a Buy Before This Key FDA Decision?
Motley Fool via Yahoo Finance· 4 months agoIovance Biotherapeutics (NASDAQ: IOVA) has reached a major turning point in its story as a company....